SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-21-002667
Filing Date
2021-05-10
Accepted
2021-05-10 16:05:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 SYNDAX PHARMACEUTICALS INC. p21-1367sc13g.htm SC 13G 104698
  Complete submission text file 0000902664-21-002667.txt   106335
Mailing Address 200 CLARENDON STREET, 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 (617) 867-2800
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) CIK: 0001165408 (see all company filings)

IRS No.: 043574590 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Subject) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89449 | Film No.: 21907052
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences